Clinical Trials Directory

Trials / Completed

CompletedNCT00857948

Dose Ranging Study of Ivermectin Treatment Conditioner in Subjects With Head Lice Infestation

A Double-Blind, Placebo-Controlled Study Comparing the Safety and Efficacy of 3 Strengths of Ivermectin Treatment Conditioner and Placebo in Subjects With Pediculus Humanus Capitis (Head Lice) Infestation

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
78 (actual)
Sponsor
Topaz Pharmaceuticals Inc · Industry
Sex
All
Age
6 Months
Healthy volunteers
Not accepted

Summary

This is a Phase 2 single center study designed to compare the safety, local tolerability, and efficacy of 3 strengths of ivermectin treatment conditioner to placebo.

Conditions

Interventions

TypeNameDescription
DRUGivermectin treatment conditionerApplication followed by thorough rinsing of the hair and scalp with water.
DRUGPlacebo, vehicle controlApplication followed by thorough rinsing of the hair and scalp with water.

Timeline

Start date
2009-03-01
Primary completion
2009-04-01
Completion
2009-04-01
First posted
2009-03-09
Last updated
2012-03-30
Results posted
2012-03-30

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00857948. Inclusion in this directory is not an endorsement.

Dose Ranging Study of Ivermectin Treatment Conditioner in Subjects With Head Lice Infestation (NCT00857948) · Clinical Trials Directory